Page 14«..10..13141516..2030..»

Are Rare Brain Diseases the Next Commercial Frontier for Gene Therapy? – MedCity News

Are Rare Brain Diseases the Next Commercial Frontier for Gene Therapy?  MedCity News

Originally posted here:
Are Rare Brain Diseases the Next Commercial Frontier for Gene Therapy? - MedCity News

Recommendation and review posted by Bethany Smith

Novartis, Voyager Ink Up-to-$1.3B Expansion of Neuro Gene Therapy Collaboration – Genetic Engineering & Biotechnology News

Novartis, Voyager Ink Up-to-$1.3B Expansion of Neuro Gene Therapy Collaboration  Genetic Engineering & Biotechnology News

Visit link:
Novartis, Voyager Ink Up-to-$1.3B Expansion of Neuro Gene Therapy Collaboration - Genetic Engineering & Biotechnology News

Recommendation and review posted by Bethany Smith

Novel switch turns genes on/off on cue, a promising step toward safer gene therapy – Phys.org

Novel switch turns genes on/off on cue, a promising step toward safer gene therapy  Phys.org

Visit link:
Novel switch turns genes on/off on cue, a promising step toward safer gene therapy - Phys.org

Recommendation and review posted by Bethany Smith

Which Therapeutic Areas Experts Think Will Gain Traction In 2024 – Clinical Leader

Which Therapeutic Areas Experts Think Will Gain Traction In 2024  Clinical Leader

Continued here:
Which Therapeutic Areas Experts Think Will Gain Traction In 2024 - Clinical Leader

Recommendation and review posted by Bethany Smith

Voyager Therapeutics and Novartis Announce Major Licensing Deal in Gene Therapy Field – Medriva

Voyager Therapeutics and Novartis Announce Major Licensing Deal in Gene Therapy Field  Medriva

Originally posted here:
Voyager Therapeutics and Novartis Announce Major Licensing Deal in Gene Therapy Field - Medriva

Recommendation and review posted by Bethany Smith

We Are About to Enter the Golden Age of Gene Therapy – Inverse

We Are About to Enter the Golden Age of Gene Therapy  Inverse

View post:
We Are About to Enter the Golden Age of Gene Therapy - Inverse

Recommendation and review posted by Bethany Smith

Revolutionizing Gene Therapy: Baylor Researchers Develop RNA-Based Switch for Therapeutic Protein Control – BNN Breaking

Revolutionizing Gene Therapy: Baylor Researchers Develop RNA-Based Switch for Therapeutic Protein Control  BNN Breaking

Read the rest here:
Revolutionizing Gene Therapy: Baylor Researchers Develop RNA-Based Switch for Therapeutic Protein Control - BNN Breaking

Recommendation and review posted by Bethany Smith

The Now: Could Science Really Extend The Human Lifespan? – GCFGlobal.org

Lesson 10: Could Science Really Extend The Human Lifespan?

/en/thenow/what-is-labgrown-meat/content/

Despite advances in medicine and nutrition, science has had difficulty extending the human lifespan beyond a certain age. Nevertheless, scientists are researching how to push beyond these limits and increase the duration and quality of a persons life. However, the big question remains: Could science really extend the human lifespan?

The science of life extension has one main goal, which is to prolong the human lifespan while maintaining youthful health. Since antiquity, people have pursued this goal through countless medicines, diets, and scientific procedures. But now, science has the knowledge to possibly make life extension a reality.

Life extension has been in the news lately because many entrepreneurs, especially within Silicon Valley, have publicly advocated and funded life extension research. Many of these advocates are incredibly optimistic because they see human aging not as inevitable but as an obstacle that will eventually be overcome.

Currently, there is no proven method of delaying or reversing the aging process. However, there are plenty of products available that will try to convince you otherwise.

Always be wary of any drug, food, or supplement that makes anti-aging claims. Also keep in mind that in the United States, the FDA only reviews supplements for safety, not for effectiveness. This means a supplement that claims to prevent aging could actually be useless. As for cosmetics that make anti-aging claims, these products are typically designed to hide the effects of aging, not reverse aging itself.

Essentially, if an anti-aging product seems too good to be true, it probably is.

Although life extension is being researched from numerous angles, genetic engineering has shown the most promise. Some methods involve replacing damaged cells with new ones, while others alter the mechanisms of DNA. In 2017, Harvard scientists discovered how to reverse aging in lab mice by changing how their DNA repairs itself. However, it's unclear if scientists will be able to duplicate this feat in humans.

While it can't delay aging itself, replacing worn organs could help people survive the more deteriorating effects of aging. Scientists have already grown kidneys and windpipes in laboratory settings using stem cells, and theyre researching how to create more complex organs like the heart and liver. There has also been significant progress with artificial organs, partially thanks to new technologies like 3D printing.

Currently, life extension is mostly research and educated guesses. Some experts believe we are not even close to breaking through the natural barriers of aging, while others believe some form of life extension will be widely available by the middle of the 21st century.

Almost everyone wants to live longer, healthier lives, but science has a long way to go before we overcome the natural limits of the human lifespan. Although life extension technology will continue to develop, major discoveries will take decades to realize, if they are realized at all.

/en/thenow/how-crispr-could-change-the-world/content/

Go here to read the rest:
The Now: Could Science Really Extend The Human Lifespan? - GCFGlobal.org

Recommendation and review posted by Bethany Smith

Preimplantation Genetic Testing Market is Expected to Reach $1.2 Billion | MarketsandMarkets. – Yahoo Finance

Preimplantation Genetic Testing Market is Expected to Reach $1.2 Billion | MarketsandMarkets.  Yahoo Finance

View original post here:
Preimplantation Genetic Testing Market is Expected to Reach $1.2 Billion | MarketsandMarkets. - Yahoo Finance

Recommendation and review posted by Bethany Smith

Sam Altman’s Life Extension Guy Warns of Injections That Cause Wild Tumor Growth – Futurism

Sam Altman's Life Extension Guy Warns of Injections That Cause Wild Tumor Growth  Futurism

Visit link:
Sam Altman's Life Extension Guy Warns of Injections That Cause Wild Tumor Growth - Futurism

Recommendation and review posted by Bethany Smith

What Is CRISPR Gene Editing and How Does It Work?

In 2013, two biochemists published a paper proclaiming theyd discovered a potentially game-changing method of manipulating genes. CRISPR which sounds like a veggie-forward gastro pub won them each a Nobel Prize.

In the years since, CRISPR (or Clustered Regularly Interspaced Short Palindromic Repeats) has lived up to the hype. Its altered the global scientific landscape and raised questions about what kinds of revolutionary changes scientists and healthcare providers could and should pursue.

What if we could make foods allergy-free and crops drought-resistant? What if we could eliminate invasive species and protect against infectious diseases like malaria? What if we could revive extinct species? What if we could remove or repair mutations that cause inherited conditions? Or create custom immunotherapies to treat an individuals cancer?

The prospects are that exciting.

If your understanding of genetics starts and ends with high school biology or the (very fictional) Jurassic Park movies youre not alone. This stuff is complicated. Thats why we asked genomics and immunotherapy expert Timothy Chan, MD, PhD, to break CRISPR down for us, so we can better understand why, over a decade later, its still got researchers so excited.

Before we jump into CRISPR, lets start with the concept of gene editing.

Gene editing is the process of altering genetic material (DNA). That could mean changing a few individual genes or an entire sequence. Research has been ongoing for more than a decade thats looking at using gene editing on mutations that cause serious health conditions in people. The goal of this gene editing research is to eliminate or correct the mutation thats causing the health condition, or has the potential to cause one, such as certain cancers. In other research studies, gene editing is being explored so a mutation isnt passed down to children at birth.

For example, the U.S. Food and Drug Administration (FDA) approved a gene therapy in late 2022 that introduces a gene needed for blood clotting into people with hemophilia B. Its one of several cellular and gene therapy products currently in use today.

There are many different techniques and applications for gene editing. CRISPR is one approach to gene editing thats showing promise in ongoing clinical trials.

Now that were clear on what gene editing is, lets focus on a specific approach: CRISPR.

Clustered Regularly Interspaced Short Palindromic Repeats, otherwise known as CRISPR, was originally identified in bacteria, as a bacterial defense system, says Dr. Chan.

Thats right. Bacteria have immune systems, too.

CRISPR contains spacers sequences of DNA left over from unfriendly viruses or other entities as well as repeating sections of genetic material. Those sequences provide acquired immunity, and form the building blocks of the gene editing system or process. It creates a sort of blueprint that allows enzymes in genetic material to make changes to sequences of DNA in living cells. One of the best-known enzymes used for this purpose is called Cas9, which is why youll sometimes hear people talk about CRISPR-Cas9.

Over the years, people have discovered that specific enzymes that allow CRISPR to work Cas9 is one of them.But there are other ones, and they can be tailored to target sequences of interest in the DNA for specific cuts to be made, Dr. Chan explains.

You can think of the underlying mechanism of CRISPR gene editing as being similar to the way magnetic shapes are drawn to each other or the way Lego blocks fit together.

The segments in CRISPR are transcribed into RNA. This RNA includes a guide sequence, which is a match to existing DNA in a persons body.

That guide sequence can be tailored to whatever you want, Dr. Chan says. And as a result, you can make specific alterations or mutations in a part of the genome that you are targeting with a high degree of accuracy.

Along for the ride with this guide sequence is an enzyme like Cas9.

When the guide sequence and enzyme find the desired DNA to edit, the enzyme can then get down to business. It attaches itself to this DNA and makes changes, whether thats a cut or alteration.

CRISPR technology has come a long way, Dr. Chan says. The first generation of CRISPR was a great way to inactivate genes. It only made a break in genes. Then, the DNA would get filled up with natural repair enzymes.

But new versions of CRISPR like CRISPR prime or CRISPR HD are more advanced.

These can allow actual replacements to occur, Dr. Chan continues. You can even very accurately replace one sequence one of the letters in the genome with another letter. And you can make specific mutations.

CRISPRs ability to make very specific, very small cuts has the potential to transform how healthcare providers can address certain genetic diseases.

Dr. Chan is optimistic about the future of CRISPR based on the success of ongoing clinical trials in human subjects. For any type of genetic diseases caused by a single mutated gene, you can use CRISPR to mutate it and make it normal. Thats why its useful. Its a way for us to change errors in the genome.

Right now, CRISPR is geared toward correcting a single change in genes, he adds. While combinations may be possible in the future, were just not there yet.

While gene editing is already in use, CRISPR is still in the clinical trials phase, Dr. Chan says. Its used all the time in research laboratories and industries, he notes. Many clinical trials are testing CRISPR in the setting of genetic diseases and cancer.

Interestingly, CRISPR can be used to detect certain diseases. The best-known example is the Sherlock CRISPR SARS-CoV-2 Kit: A COVID-19 test that received emergency use authorization (EAU) from the FDA in 2020.

But theres no FDA-approved CRISPR therapy right now. The clinical trials are ongoing, he says.

These include trials looking at CRISPR to correct genetic diseases such as cystic fibrosis, Huntingtons disease and muscular dystrophy.

Dr. Chan adds that there are also major clinical trials in process for blood disorders, where CRISPR is being used to correct the gene alteration that causes the condition. As one example, he cites a promising trial looking at CRISPR-Cas9 gene editing for sickle cell disease and -thalassemia, written about in an early 2021 issue of the New England Journal of Medicine. -thalassemia is an inherited blood disorder that impacts the bodys ability to create hemoglobin an iron-dense protein that serves as the primary ingredient in red blood cells.

There are also clinical trials looking to see if CRISPR can be used to treat certain cancers. Dr. Chan notes that chimeric antigen receptor (CAR)T-cell therapy is one of the first gene therapies approved for leukemias. Current research is looking at whether CRISPR technology can make this treatment even more effective.

In CAR T-cell therapy, you take out T-cells from someone and put in a receptor a new way for these cells to target something on cancer cells and then put these cells back in the patient, he explains. Researchers are running trials now where they use CRISPR to alter those T-cells to make them even more active.

CRISPR therapies can take on many different forms. CRISPR has been inserted directly into the body before. It was famously injected into the eyes of seven people with a rare hereditary blindness disorder in 2020, two of whom later told NPR that they regained some ability to see colors. There are human trials in process right now that deliver CRISPR through gels and creams, through food or drink, skin grafts or injections. Ex-vivo delivery is also common: Thats when CRISPR is used to modify a cell outside the body. The cells are then re-inserted into the body using a harmless virus.

The results have been promising so far. I do believe in the next three to five years possibly even sooner were going to see approval to treat some diseases, Dr. Chan states.

With any type of CRISPR therapy, Dr. Chan says theres a risk of getting off-target effects or unexpected side effects.

Whenever youre altering something as fundamental as DNA, you just dont know what might happen he explains. Theres always a chance for the unexpected. You can potentially have effects on your DNA that were not intended.

At the moment, he doesnt have any specific examples of what these effects might be and he notes that existing research suggests the risk is pretty low. Still, data from future research might tell a different story.

Dr. Chan nevertheless sees a lot of potential for CRISPR in the coming years.

The field is moving very quickly, he says. Were seeing continual improvement of the actual CRISPR tools being used.

Its getting more accurate and more flexible in terms of what you can do. There are various engineered modified variants of CRISPR now that are allowing very specific, very accurate changes with fewer off-target effects. So, I think the future is very bright.

View original post here:
What Is CRISPR Gene Editing and How Does It Work?

Recommendation and review posted by Bethany Smith

This first CRISPR treatment is just the beginning. Heres what’s next – Fast Company

This first CRISPR treatment is just the beginning. Heres what's next  Fast Company

Read the original:
This first CRISPR treatment is just the beginning. Heres what's next - Fast Company

Recommendation and review posted by Bethany Smith

The Age of Crispr Medicine Is Here – WIRED

The Age of Crispr Medicine Is Here  WIRED

See the article here:
The Age of Crispr Medicine Is Here - WIRED

Recommendation and review posted by Bethany Smith

6 Words That Explain Why CRISPR Stock Isn’t Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy – Yahoo Finance

6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy  Yahoo Finance

Here is the original post:
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy - Yahoo Finance

Recommendation and review posted by Bethany Smith

Crispr Therapeutics Medical Chief Morrow to Resign – The Wall Street Journal

Crispr Therapeutics Medical Chief Morrow to Resign  The Wall Street Journal

The rest is here:
Crispr Therapeutics Medical Chief Morrow to Resign - The Wall Street Journal

Recommendation and review posted by Bethany Smith

Crispr Therapeutics chief medical officer is resigning – MarketWatch

Crispr Therapeutics chief medical officer is resigning  MarketWatch

Go here to read the rest:
Crispr Therapeutics chief medical officer is resigning - MarketWatch

Recommendation and review posted by Bethany Smith

3 Reasons to Buy CRISPR Therapeutics Stock Like There’s No Tomorrow – Yahoo Finance

3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow  Yahoo Finance

See the original post here:
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow - Yahoo Finance

Recommendation and review posted by Bethany Smith

CAR T Therapy May Cause Rare Cancer & How CRISPR Could Be The Solution – Forbes

CAR T Therapy May Cause Rare Cancer & How CRISPR Could Be The Solution  Forbes

Read more:
CAR T Therapy May Cause Rare Cancer & How CRISPR Could Be The Solution - Forbes

Recommendation and review posted by Bethany Smith

CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief – InvestorPlace

CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief  InvestorPlace

Go here to read the rest:
CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief - InvestorPlace

Recommendation and review posted by Bethany Smith

With the promise of saving millions of lives, CRISPR medicine is born – EL PAS USA

With the promise of saving millions of lives, CRISPR medicine is born  EL PAS USA

See original here:
With the promise of saving millions of lives, CRISPR medicine is born - EL PAS USA

Recommendation and review posted by Bethany Smith

Casgevy: the world’s first CRISPR therapy – Epigram

Casgevy: the world's first CRISPR therapy  Epigram

See original here:
Casgevy: the world's first CRISPR therapy - Epigram

Recommendation and review posted by Bethany Smith

Embryonic-stem-cell-derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions … – Nature.com

Embryonic-stem-cell-derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions ...  Nature.com

Read more here:
Embryonic-stem-cell-derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions ... - Nature.com

Recommendation and review posted by Bethany Smith

New insights about the development of hematopoietic stem cells – Drug Target Review

New insights about the development of hematopoietic stem cells  Drug Target Review

Read this article:
New insights about the development of hematopoietic stem cells - Drug Target Review

Recommendation and review posted by Bethany Smith

A niche topic: understanding the development of hematopoietic stem cells – Fred Hutchinson Cancer Center

A niche topic: understanding the development of hematopoietic stem cells  Fred Hutchinson Cancer Center

Read more from the original source:
A niche topic: understanding the development of hematopoietic stem cells - Fred Hutchinson Cancer Center

Recommendation and review posted by Bethany Smith

Hypopituitarism: Symptoms, causes, and treatment – Medical News Today

Hypopituitarism: Symptoms, causes, and treatment  Medical News Today

Continue reading here:
Hypopituitarism: Symptoms, causes, and treatment - Medical News Today

Recommendation and review posted by Bethany Smith


Archives